QA: Immix Biopharma Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001873835_2026_Immix_Biopharma_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001873835, Immix Biopharma Inc

  xvar xval
0 AssetsCurrent 101,237,755
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,521,621
3 remainder_Assets 1,080,965
4 LiabilitiesCurrent 10,110,546
5 LiabilitiesNoncurrent 933,625
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,334,356
9 ResearchAndDevelopmentExpense 40,325,194
10 remainder_Expenses 34,112
11 remainder_Revenues 0
12 remainder_NetIncome 710,991
13 remainder_ComprehensiveNetIncome -713
  yvar yval
0 Assets 104,840,341
1 Liabilities 11,044,171
2 Expenses 64,693,662
3 Revenues 0
4 StockholdersEquity 93,796,170
5 NetIncome -63,982,671
6 ComprehensiveNetIncome -63,983,028
7 BaseVar 90,644,939
8 EconomicCapitalRatiobeforeLimitedLiability 2.42
9 EconomicCapitalRatio 3.31

Edgar->Model Mapping

Feature Distribution

Change over Time